Grants and Contributions

The Project Grant program is expected to:
• Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercialization;
• Promote relevant collaborations across disciplines, professions, and sectors; and
• Contribute to the creation and use of health-related knowledge.

This award was established to recognize the excellence of cancer research being conducted in Canada. This award will be given annually to the highest-ranking Early Career Researchers in the Project Grant competition that fall within the CIHR Institute of Cancer Research (CIHR-ICR) mandate:
• ICR has a mandate to support research that reduces the burden of cancer on individuals and families through prevention strategies, screening, diagnosis, effective treatments, psycho-social support systems, and palliation.

This award was established to recognize the excellence of cancer research being conducted in Canada. This award will be given annually to the highest-ranking Early Career Researchers in the Project Grant competition that fall within the CIHR Institute of Cancer Research (CIHR-ICR) mandate:
• ICR has a mandate to support research that reduces the burden of cancer on individuals and families through prevention strategies, screening, diagnosis, effective treatments, psycho-social support systems, and palliation.

The CIHR Institute of Gender and Health (CIHR-IGH) will fund applications that are relevant to its mandate and research priorities, as described in our new Research Priority Plan, and that are aligned with at least one of the following research areas.
Research Areas:
1. Advancing intersectionality in sex and gender science (1 grant)
2. Understanding sex and gender mechanisms and processes (1 grant)
3. Sex and gender science for health equity in priority communities (2 grants)

This Priority Announcement (PA) is led by the Institute of Circulatory and Respiratory Health (CIHR-ICRH) in partnership with Cystic Fibrosis Canada.

The CIHR-ICRH has the broad mandate of supporting research on the heart, lung, brain (stroke), blood, blood vessels, critical and intensive care, and sleep.
Cystic Fibrosis Canada has the mandate to act boldly for all Canadians living with cystic fibrosis so they can live longer, healthier, fuller lives.
This Priority Announcement is focused on cystic fibrosis across the lifespan.

The proposed research should inform the management of cystic fibrosis (CF) across the lifespan.

• Examples include, but are not limited to:
o Understanding the changing health issues of individuals with CF as they age
o Understanding the long-term effects of medications (including CF transmembrane conductance regulators (CFTR) modulators) in CF over the lifespan
o Understanding the impact of modulators on fetal development or early childhood
o Understanding changes in treatments as people with CF age
o Strategies to maintain and enhance lung health over the lifespan
o Transitions from pediatric to adult CF care
o Preventative strategies for cardiovascular and other complications
• Research focusing on more than one (1) developmental or intergenerational period over the lifespan is encouraged. Examples include, but are not limited to:
o one developmental period before and after age 18, or
o different developmental periods across generations (e.g. biological parent and fetus or offspring), or
o two (2) developmental periods in females related to puberty, child-bearing age and menopause.
• Sex and gender consideration should be integrated as appropriate.

The CIHR Institute of Cancer Research (CIHR-ICR) has a mandate to support research that reduces the burden of cancer on individuals and families through prevention strategies, screening, diagnosis, effective treatments, psycho-social support systems, and palliation.

This PA will fund Cancer research in the following priority areas:

• Cancer Prevention and/or Early Detection of Cancer
o research that prevents the onset of cancer (lowers cancer risk) and/or reduces the severity of the disease through early detection when it is at its most treatable.
• Cancer Survivorship
o research that mitigates the challenges experienced along the cancer survivorship journey and improves the health outcomes for cancer survivors of all ages after cancer treatment ends.
o specifically in the areas of:
¿ Late and long-term effects of cancer treatment
¿ Survivors’ experiences and outcomes
¿ Models of care for cancer survivorship
o This PA will not fund research focused on improving end-of-life care.

This PA supports research that creates new knowledge and/or moves it into practice in the health system, communities, workplaces, and in the daily lives of Canadians.

The CIHR Institute of Indigenous Peoples’ Health (CIHR-IIPH) will provide funding for applications that are relevant to its mandate.

• The CIHR-IIPH fosters the advancement of a national health research agenda to improve and promote the health of First Nations, Inuit and Métis Peoples in Canada, through research, knowledge translation and capacity building. The Institute's pursuit of research excellence is enhanced by respect for community research priorities and Indigenous knowledges, values and cultures.

Research Areas:

• First Nations Health
• Inuit Health
• Métis Health
• Indigenous Health

The Centre for Research on Pandemic Preparedness and Health Emergencies (CRPPHE) is housed at CIHR with a mandate to grow Canada's research leadership in preparedness, prevention, response, and recovery from pandemics and public health emergencies, including by building and supporting Canadian research capacity in the field.

CRPPHE will offer funding for bridge grants to research projects that are aligned with the CRPPHE goal and objectives and the CRPPHE Interim Investment Plan 2023-2025, and that have a primary research objective related to preparing for and/or responding to existing and future pandemics and other health emergencies*.

*For the purpose of this Priority Announcement, a health emergency is defined as:

A present or imminent event or phenomenon, of a temporary, acute nature, with actual or potential significant negative impacts on human health, resulting in:
• A serious disruption of the functioning of a community; and/or
• The declaration of a state of emergency by a municipal, provincial/territorial, federal and/or Indigenous government, or international organization with a health research mandate, and that;
• Requires prompt research action to protect and strengthen human health.

This Priority Announcement (PA) is led by Canada’s Strategy for Patient-Oriented Research and aims to support Patient-Oriented Research (POR*) projects and Innovative Clinical Trials (iCT) projects.

This Priority Announcement (PA) is led by Canada’s Strategy for Patient-Oriented Research and aims to support Patient-Oriented Research (POR*) projects and Innovative Clinical Trials (iCT) projects.